Persistence of cyclicity of the plasma dopamine metabolite. Homovanillic acid, in neuroleptic treated schizophrenic patients
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 44 (16) , 1117-1121
- https://doi.org/10.1016/0024-3205(89)90339-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Longitudinal Measurement of Plasma Homovanillic Acid Levels in Schizophrenic PatientsArchives of General Psychiatry, 1986
- Acute and chronic effects of haloperidol on plasma and brain homovanillic acid in the ratBiological Psychiatry, 1986
- Plasma Homovanillic Acid Concentration and the Severity of Schizophrenic IllnessScience, 1985
- Neuroleptic-Induced Decrease in Plasma Homovanillic Acid and Antipsychotic Activity in Schizophrenic PatientsScience, 1984
- Plasma homovanillic acid as an index of brain dopamine metabolism: Enhancement with debrisoquinLife Sciences, 1983
- Influence of dopamine agonists on plasma and brain levels of homovanillic acidLife Sciences, 1982
- Brain contribution to the haloperidol-induced increase in plasma homovanillic acidEuropean Journal of Pharmacology, 1981
- 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of central dopaminergic activityEuropean Journal of Pharmacology, 1979
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963